Welcome to our dedicated page for Charles & Colvard news (Ticker: CTHR), a resource for investors and traders seeking the latest updates and insights on Charles & Colvard stock.
Charles & Colvard, Ltd. (CTHR) generates news that spans product strategy, financing, governance, and stock listing developments, reflecting its role as a fine jewelry company focused on moissanite and lab-grown diamonds. Company press releases emphasize its identity as the original creator of lab-grown moissanite and a promoter of Made, not Mined™ above-ground gemstones and recycled precious metals, while also documenting key events that matter to investors and industry observers.
News coverage for Charles & Colvard often highlights strategic partnerships and product-related initiatives. Examples include its alliance with Ethara Capital LLC, an affiliate of Bhanderi Lab Grown Diamonds Inc., to expand its Caydia® lab-grown diamond offerings for both consumers and wholesale markets, and its exclusive strategic alliance with the International Gemological Institute (IGI) to introduce grading reports for Forever One™ moissanite gemstones and jewelry. Another notable development is its partnership with VideoShops, a social commerce network, which brings the company’s Made, not Mined™ jewelry catalog into customer-run storefronts and peer-to-peer selling environments.
Investors following CTHR news will also see regulatory and capital markets updates. The company has reported on a one-for-ten reverse stock split intended to address Nasdaq’s minimum bid price requirement, subsequent notices of non-compliance related to delayed SEC filings, and an April 2025 announcement that Nasdaq would suspend trading and delist its common stock, with the company expecting quotation on the OTC Experts Market. Additional news includes arbitration outcomes, shareholder activism and proxy-related communications, and disclosures about financing agreements such as the Convertible Secured Note Purchase Agreement with Ethara Capital LLC.
This news page allows readers to track how Charles & Colvard’s branding around Forever One™ moissanite and Caydia® lab-grown diamonds intersects with governance changes, litigation, financing, and trading status updates. Regularly reviewing CTHR news can help market participants understand both the company’s jewelry-focused initiatives and the risks and structural changes described in its public statements.
Charles & Colvard, Ltd. (Nasdaq: CTHR) is set to unveil its first brick-and-mortar showroom on October 24, 2022, at its Morrisville, NC campus. The 2,000 square foot showroom aims to enhance customer engagement and education about lab-grown gemstones. It will showcase a full range of offerings, including new collections like the Caydia® lab-grown diamond men's bands. Company leaders emphasize the showroom's role in helping consumers understand the benefits of responsibly sourced jewelry. The showroom will also host private events to connect with local businesses.
Charles & Colvard (Nasdaq: CTHR) has announced the launch of a new collection featuring lab-grown ruby, sapphire, and emerald gemstones. This initiative adds vibrant color to their Made, Not Mined™ jewelry line, aimed at fashion-forward consumers. The gemstones are crafted to AAA quality standards, enhancing clarity and polish, which are often unattainable in mined stones. The company emphasizes its commitment to redefining the fine jewelry industry with sustainable choices and trendy designs. Their latest offerings align with a growing fashion trend identified by Vogue as
Charles & Colvard (Nasdaq: CTHR) has launched its first line of men's diamond fashion bands featuring Caydia® lab-grown diamonds and 14K recycled gold. This new collection, part of the Signature Collection, aims to expand their market presence in lab-grown diamond jewelry. CEO Don O'Connell emphasized the brand's commitment to combining traditional design with modern aesthetics. The company aims to be a leading destination for lab-grown diamond jewelry, reinforcing their ethical stance of using exclusively Made, Not Mined™ gemstones.
Charles & Colvard reported $9.3 million in net sales for Q4 FY 2022, a 4% decline year-over-year. However, the company achieved a record $43.1 million in net sales for FY 2022, a 10% increase from the previous year. Lab-grown diamond sales soared by 173%, while moissanite sales grew by 13%. The firm recorded a gross margin of 47% and $2.4 million in net income, translating to $0.08 earnings per diluted share. Cash reserves stood strong at $21.2 million. The company maintained profitability over eight consecutive quarters.
Charles & Colvard, Ltd. (Nasdaq: CTHR) will host an investor conference call on September 1, 2022, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year ending June 30, 2022. The financial results will be released after market close on the same day. Interested participants can join via telephone or access the live webcast through the Investor Relations section of the company's website. A replay will be available until September 8, 2022.
Charles & Colvard, Ltd. (Nasdaq: CTHR) unveils its new Couture Collection, featuring 50 pieces of luxury jewelry made with Caydia® lab-grown diamonds and recycled metals. Highlights include stunning 10-carat earrings and 12-carat tennis bracelets aimed at luxury consumers. CEO Don O'Connell emphasizes a commitment to responsible luxury, aiming to redefine high couture jewelry. The collection showcases diverse gemstone cuts and signifies the company's leadership in lab-grown gems. Consumers can explore the Couture Collection on their website.
Charles & Colvard reported $9.8 million in net sales for the quarter ended March 31, 2022, marking a 3% increase year-over-year. The company generated $1.1 million in cash flow from operations and increased total cash to $21.9 million. A new $5 million stock buyback program was announced, demonstrating confidence in the company's direction. Revenue growth was primarily driven by a 141% surge in lab-grown diamond sales and a 10% increase in moissanite sales. However, operating expenses rose 22% to $4 million.
Charles & Colvard (Nasdaq: CTHR) has entered a strategic distribution agreement with Cooksongold, a leading wholesale jewelry supplier in the UK. This partnership aims to expand Charles & Colvard's presence in Europe, specifically for their Forever One moissanite and Moissanite by Charles & Colvard brands. Customers will benefit from next-day delivery options, highlighting the company's commitment to sustainability and increased accessibility to lab-grown gemstones.
Charles & Colvard, Ltd. (Nasdaq: CTHR), a leader in lab-grown gemstones, plans to host an investor conference call on May 5, 2022, at 8:00 a.m. ET to discuss its financial results for the third quarter of fiscal year 2022, ending March 31, 2022. The earnings report will be released before the market opens that day. The call will be accessible via a live webcast on the company’s Investor Relations page.
Charles & Colvard, Ltd. (Nasdaq: CTHR) will host an investor conference call to discuss its financial results for the third quarter of fiscal year 2022 on May 5, 2022, at 8:00 a.m. ET. The financial results will be released after the market closes on the same day. Investors can access the call via webcast on the Company's Investor Relations website or participate via telephone. A replay will be available until May 12, 2022. Charles & Colvard specializes in lab-grown gemstones, offering the Forever One moissanite and Caydia lab-grown diamonds.